Exagen Raises $7M in Series B Private-Equity Round

genomeweb
360dx

Exagen Raises $7M in Series B Private-Equity Round

Jun 28, 2005

NEW YORK, June 28 (GenomeWeb News) - Exagen Diagnostics has raised $7 million in a Series B round of private-equity financing, the company said today.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

MBS, Intas Science Imaging Instruments Sign Distribution Deal for Thermal Cycler in Germany
Pancreatic Cancer Risk Linked to Germline Mutations in Six Cancer Predisposition Genes
MS Risk Linked to HLA Haplotype Mediated by Altered Methylation
Genetic Technologies, Swisstec Reach Deal on JV
Grifols Gets FDA Clearance for Two Blood Screening Assays on Procleix Panther System
Natera, Institut Jules Bordet Ink Breast Cancer Research Collaboration

The Scan

Dual Listings Sought

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

Allocating the Grant Pie

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

More Proposed for NSF

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

This Week in PNAS

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.

Main menu